SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-133897
Filing Date
2019-05-02
Accepted
2019-05-02 08:08:02
Documents
1
Effectiveness Date
2019-05-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A d708138ddefa14a.htm DEFA14A 27487
  Complete submission text file 0001193125-19-133897.txt   28516
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35921 | Film No.: 19789811
SIC: 2834 Pharmaceutical Preparations